Healthcare Industry News: Nakashima
News Release - October 26, 2017
Teijin Nakashima Medical to Acquire Spinal-related Business of Century MedicalTokyo, Japan, October 26, 2017 -- (Healthcare Sales & Marketing Network) -- Teijin Nakashima Medical Co., Ltd., a Teijin group
Teijin has been expanding its commercial involvement with implantable medical devices, including by acquiring a stake in Teijin Nakashima Medical and establishing Teijin Medical Technologies to develop and distribute absorbent bone-connecting material. Spinal implant sales, which account for the third largest orthopedic implant market after artificial joints and bone fixation devices, are expected to continue growing as the Japanese ages.
Teijin Nakashima Medicalís decision to acquire this promising business also reflects its high appraisal of Century Medicalís development, marketing and sales capabilities, in addition to the high quality of its products. Teijin Nakashima Medical will initially focus on expanding sales of spine-fixation devices and spine cages, as well as leverage the two companiesí advanced technologies to develop innovative new products.
The Teijin group, which is targeting annual sales of 10 billion yen in the implantable medical device business by 2020, looks forward to further business growth as a result of entering the spinal device field.
About the Teijin Group
Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the areas of environmental value; safety, security and disaster mitigation; and demographic change and increased health consciousness. Its main fields of operation are high-performance fibers such as aramid, carbon fibers & composites, healthcare, films, resin & plastic processing, polyester fibers, products converting and IT. The group has some 170 companies and around 19,000 employees spread out over 20 countries worldwide. It posted consolidated sales of JPY741.3 billion (USD 6.5 billion) and total assets of JPY 964.1 billion (USD 8.5 billion) in the fiscal year ending March 31, 2017. Please visit www.teijin.com
Source: Teijin Nakashima Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.